首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer
【2h】

Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer

机译:SARS冠状病毒主要蛋白酶作为活性C2晶体学二聚体的结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The 34 kDa main proteinase (Mpro) from the severe acute respiratory syndrome coronavirus (SARS-CoV) plays an important role in the virus life cycle through the specific processing of viral polyproteins. As such, SARS-CoV Mpro is a key target for the identification of specific inhibitors directed against the SARS virus. With a view to facilitating the development of such compounds, crystals were obtained of the enzyme at pH 6.5 in the orthorhombic space group P21212 that diffract to a resolution of 1.9 Å. These crystals contain one monomer per asymmetric unit and the biologically active dimer is generated via the crystallographic twofold axis. The conformation of the catalytic site indicates that the enzyme is active in the crystalline form and thus suitable for structure-based inhibition studies.
机译:严重急性呼吸系统综合症冠状病毒(SARS-CoV)中的34 kDa主要蛋白酶(M pro )通过病毒多蛋白的特异性加工在病毒的生命周期中发挥着重要作用。因此,SARS-CoV M pro 是鉴定针对SARS病毒的特定抑制剂的关键目标。为了促进这类化合物的发展,在正交晶空间群P21212中在pH 6.5下获得了该酶的晶体,该晶体衍射至1.9的分辨率。这些晶体的每个不对称单元包含一种单体,并且生物活性二聚体通过晶体学双轴产生。催化位点的构象表明该酶以晶体形式具有活性,因此适用于基于结构的抑制研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号